Table of contents

May 2008 Volume 4 No 5

Top

Editorial

The unrecognized costs of delirium

C Dennis Barton and J Raymond DePaulo

233

doi:10.1038/ncpneuro0809 | Full Text | PDF (83K)


Top

Viewpoints

Clinically isolated syndrome: the rationale for early treatment

Giancarlo Comi

234

Immunotherapy seems to alter the natural course of multiple sclerosis (MS), so there is a general view that treatment should be initiated as soon as a diagnosis is made. In this Viewpoint, Giancarlo Comi makes a case for extending the early treatment approach to patients with a first neurological event suggestive of MS.

doi:10.1038/ncpneuro0772 | Full Text | PDF (99K)

Immunotherapy for clinically isolated syndrome? Not necessarily...

Aksel Siva

236

Multiple sclerosis (MS) is a complex disease with a high degree of clinical and neuropathological variability between patients. In this Viewpoint, Aksel Siva argues that such a heterogeneous disease demands a heterogeneous approach to treatment and questions the practice of initiating long-term immunotherapy before the MS diagnosis has become definite.

doi:10.1038/ncpneuro0774 | Full Text | PDF (98K)


Top

Research Highlights

Predictive markers for response to interferon beta therapy in MS

238

doi:10.1038/ncpneuro0777 | Full Text | PDF (74K)

Listening to music can help patients in early stroke recovery

238

doi:10.1038/ncpneuro0778 | Full Text | PDF (79K)

Use of a brain–computer interface in patients with hand plegia after stroke

239

doi:10.1038/ncpneuro0779 | Full Text | PDF (72K)

Lithium inhibits progression of amyotrophic lateral sclerosis

239

doi:10.1038/ncpneuro0780 | Full Text | PDF (77K)

B-cell depletion shows therapeutic potential in relapsing–remitting MS

240

doi:10.1038/ncpneuro0781 | Full Text | PDF (72K)

Calcium-channel blockers linked to reduced risk of Parkinson's disease

240

doi:10.1038/ncpneuro0783 | Full Text | PDF (78K)

Study finds no link between plasma lipid levels and risk of mild cognitive impairment

241

doi:10.1038/ncpneuro0782 | Full Text | PDF (73K)

Variants in ABCB1 can predict patient response to antidepressant drugs

241

doi:10.1038/ncpneuro0784 | Full Text | PDF (73K)


Top

Practice Points

Bevacizumab combined with irinotecan for recurrent glioblastoma multiforme—improvement over available therapy?

Sajeel Chowdhary and Eric T Wong

242

doi:10.1038/ncpneuro0712 | Full Text | PDF (102K)

Investigating vascular myelopathy—when can magnetic resonance angiography replace digital subtraction angiography?

James V Byrne

244

doi:10.1038/ncpneuro0747 | Full Text | PDF (100K)

Migraine in adolescents: towards an easy-to-use screening tool

Marcelo E Bigal and Richard B Lipton

246

doi:10.1038/ncpneuro0754 | Full Text | PDF (104K)

How SAFE is albumin for fluid resuscitation in critically ill patients with traumatic brain injury?

Peter J Kirkpatrick, Ming-Yuan Tseng and Peter JA Hutchinson

248

doi:10.1038/ncpneuro0768 | Full Text | PDF (104K)

Should angioplasty and stenting be performed before CAGB in patients with asymptomatic carotid stenosis?

Larry B Goldstein

250

doi:10.1038/ncpneuro0771 | Full Text | PDF (103K)

Should adults with suspected bacterial meningitis receive adjunctive dexamethasone?

Diederik van de Beek and Jan de Gans

252

doi:10.1038/ncpneuro0767 | Full Text | PDF (101K)


Top

Reviews

Sleep disturbances in patients with parkinsonism

Valérie Cochen De Cock, Marie Vidailhet and Isabelle Arnulf

254

Sleep disturbances, such as insomnia, rapid eye movement sleep disorders and excessive daytime sleepiness, are symptoms that are commonly associated with movement disorders. This article discusses the prevalence and underlying mechanisms of sleep disturbances in patients with Parkinson's disease or atypical parkinsonism, and proposes therapeutic approaches that could benefit both the patient and their sleeping partner.

doi:10.1038/ncpneuro0775 | Full Text | PDF (543K)

Continuing Medical Education

Technology Insight: imaging neurodegeneration in Parkinson's disease

David J Brooks

267

Currently, idiopathic Parkinson's disease can only be diagnosed definitively by the demonstration of intracellular Lewy body inclusions on histological specimens of brain tissue—an approach that is impractical in living individuals. In this Review, David Brooks discusses recent advances in noninvasive imaging approaches that are providing important insights into the structural, pathophysiological and pharmacological changes associated with Parkinson's disease, and could have major implications for the future diagnosis and management of this condition.

doi:10.1038/ncpneuro0773 | Full Text | PDF (516K)


Top

Case Studies

Amyloid-beta-related angiitis: a rare cause of recurrent transient neurological symptoms

Amy Amick, Jeff Joseph, Nicholas Silvestri and Magdy Selim

279

This article describes the case of a female patient who presented with transient right-sided weakness, and went on to develop further transient neurological signs and symptoms. A diagnosis of amyloid-beta-related angiitis was made at autopsy following a sudden, fatal intracerebral hemorrhage. The authors highlight the importance of considering this diagnosis in patients with difficult-to-localize transient neurological symptoms.

doi:10.1038/ncpneuro0769 | Full Text | PDF (281K)

Continuing Medical Education

A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody

Sabine Mueller, Dena B Dubal and S Andrew Josephson

284

This Case Study describes a 63-year-old woman with a history of metastatic breast cancer who presented with rapidly progressing myelopathic symptoms and an elevated titer for the neuromyelitis optic antibody. The appearance of myelopathy correlated with recurrence of the patient's breast cancer on two separate occasions, and the authors suggest this case represents a possible paraneoplastic syndrome associated with the neuromyelitis antibody.

doi:10.1038/ncpneuro0765 | Full Text | PDF (176K)


Extra navigation

.

ADVERTISEMENT